No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study Read More > February 1, 2001
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. Read More > January 1, 2000
Role of Serotoninergic Neurons and 5-HT Receptors in the Action of Hallucinogens Read More > January 1, 2000
Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness Read More > January 1, 1999
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action Read More > December 1, 1998
Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity Read More > July 2, 1997
Ketamine psychedelic therapy (KPT): a review of the results of ten years of research Read More > January 1, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis Read More > October 14, 1996
